FDA Neurological Devices Panel
This article was originally published in The Gray Sheet
Executive Summary
Cancels scheduled Jan. 28 meeting. Analysts note that the panel was expected to review Medtronic's Activa neurostimulation device for Parkinson's treatment (1"The Gray Sheet" Nov. 29, p. 15). Quarterly panel meetings in 2000 are tentatively scheduled on May 11-12, Aug. 17-18, and Nov. 16-17